Skip to main content
. 2022 Feb 22;15:569–579. doi: 10.2147/IDR.S347343

Table 4.

CRKP MIC50 and MIC90 of CRKP

Projects Quantity Break Point MIC50 MIC90 MIC Range
Tigecycline 962 S≤0.03 R≥0.25 0.5 2 0.02–64
Compound sulfamethoxazole 4978 S≤2 R≥4 4 16 0.25–128
Ciprofloxacin 5430 S≤1 R≥4a 4 8 0.01–64
Etapenan 724 S≤0.5 R≥2 8 16 0.25–64
Levofloxacin 5646 S≤2 R≥8 8 16 0.06–64
Tobramycin 3546 S≤4 R≥16 16 16 0.5–32
Meropenem 5359 S≤1 R≥4 16 32 0.06–128
Gentamicin 5370 S≤4 R≥16 16 16 0.5–32
Amikacin 5479 S≤16 R≥64 16 64 1–128
Imipenem 5658 S≤1 R≥4 16 32 0.12–64
Amoxicillin/clavulanic acid 1027 S≤8 R≥32 32 32 0.5–64
Cefoxitin 2218 S≤8 R≥32 32 64 1–128
Cefepime 5694 S≤2 R≥16 32 64 0.12–128
Cefotaxime 1327 S≤1 R≥4 64 64 0.12–128
Aztreonam 3738 S≤4 R≥16 64 128 0.25–128
Cefuroxime 4528 S≤8 R≥32 64 128 1–128
Ceftriaxone 4624 S≤1 R≥4 64 128 0.12–128
Cefazolin 5074 S≤16 R≥32 64 128 1–128
Ceftazidime 5364 S≤4 R≥16 64 64 0.06–128
Piperacillin 3414 S≤16 R≥128 128 256 2–256
Piperacillin/tazobactam 5643 S≤16 R≥128 128 256 0.5–256

Note: MIC50/MIC90, MIC50 and MIC90 can inhibit 50% or 90% of the tested bacteria.

Abbreviation: MIC, minimum inhibitory concentration.